Skip to content
Use caution Medical device recall · FDA · Published October 19, 2023

Siemens epoc NXS Host Blood Analyzer: Erroneous Test Results Risk

Siemens Healthcare recalls epoc NXS Host Blood Analysis System with software versions 4.9.4 to 4.11.11 due to potential erroneous test results, risking misdiagnosis of hyperkalemia or hyperglycemia.

🇺🇸 FDA recall #Z-0601-2024Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics Inc2 Edgewater Dr · Norwood, MA 02062-4637
✎ GovInfoNow plain-language explainer

Siemens is recalling its epoc NXS Host Blood Analysis System because a software issue can cause printed test results to include incorrect analytes from previous tests. This could lead to missing hyperkalemia or hyperglycemia diagnoses, which might require urgent treatment. Read more at govinfonow.com/recall/57034-siemens-epoc-nxs-host-blood-analyzer-erroneous-test-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/57034-siemens-epoc-nxs-host-blood-analyzer-erroneous-test-results-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0601-2024

Cite this page

“Siemens epoc NXS Host Blood Analyzer: Erroneous Test Results Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/57034-siemens-epoc-nxs-host-blood-analyzer-erroneous-test-results-risk. Based on FDA recall #Z-0601-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0601-2024%22&limit=1).

The FDA announced on Oct. 19, 2023, that Siemens Healthcare Diagnostics Inc. is recalling the epoc NXS Host Blood Analysis System due to a software error causing erroneous printed results. The agency said the issue may lead to failure to diagnose hyperkalemia or inappropriate treatment for hyperglycemia.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: epoc NXS Host Blood Analysis System
  • Siemens Material Numbers: 11413497 (EU), 11413475 (US), 11413506 (CA), 11413517
  • Software versions: 4.9.4 to 4.11.11
  • UDI-DI codes: 00630414605760, 00630414606095, 00630414605821, 00630414605838, 00630414605678, 00630414605814, 00630414612447, 00630414631028
  • Units affected: 10,183 devices

The hazard

According to the FDA, a software problem causes erroneous results to be printed, saved, or transferred when the epoc NXS Host and Delete Blood Tests feature is enabled. The worst possible outcome may result in a failure to diagnose hyperkalemia due to an erroneous depressed potassium level or inappropriate treatment to hyperglycemia due to an erroneous glucose reading.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has had 150 other recalls on record since June 7, 2017. Other recent recalls of similar products include Beckman Coulter DxH Diluent Recall (Nov. 10, 2025) and Diagnostica Stago Asserachrom HPIA Kit Recall (Dec. 15, 2025).

How to tell if you have this one

Check the software version on your epoc NXS Host Blood Analysis System. The affected units have material numbers like 11413497 (EU), 11413475 (US), and software versions from 4.9.4 to 4.11.11.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Review the software version on your epoc NXS Host Blood Analysis System to determine if it is affected (versions 4.9.4 to 4.11.11).

  2. Contact Siemens

    Reach out to Siemens Healthcare for guidance on whether your system needs correction or update.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide. Global Distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Oct 19, 202312. FDA classified it Class II: Dec 20, 202323. Published in FDA’s Enforcement Report: Dec 27, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0601-2024 (October 19, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0601-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA